ABVD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: ABVD; ABVD regimen; Adriamycin-Bleomycin-Vinblastine-Dacarbazine regimen; BLEO/DOX/DTIC/VBL; Bleomycin/Dacarbazine/Doxorubicin/Vinblastine regimen

Overview

ABVD regimen refers to an a chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination with radiation therapy, for the primary treatment of Hodgkin lymphoma.^[1]^[2]

Regimen

ADoxorubicin (Adriamycin)

BBleomycin

VVinblastine

DDacarbazine

Indications

Primary treatment of Hodgkin’s lymphoma ^[3]

References

↑ “NCI Thesaurus”.
↑ “R-CHOP – National Cancer Institute”.
↑ Nagai H (2014). “[Hodgkin lymphoma]”. Nihon Rinsho. 72 (6): 1099–103. PMID 25016811.

[1] “NCI Thesaurus”.

[2] “R-CHOP – National Cancer Institute”.

[pmid25016811-3] Nagai H (2014). “[Hodgkin lymphoma]”. Nihon Rinsho. 72 (6): 1099–103. PMID 25016811.

[1]

[2]

[3]

ABVD regimen

Overview

Regimen

Indications

References

Looking for the patient version?